Hood River Capital Management LLC Axsome Therapeutics, Inc. Transaction History
Hood River Capital Management LLC
- $6.2 Billion
- Q2 2025
A detailed history of Hood River Capital Management LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Hood River Capital Management LLC holds 371,104 shares of AXSM stock, worth $43.3 Million. This represents 0.62% of its overall portfolio holdings.
Number of Shares
371,104Holding current value
$43.3 Million% of portfolio
0.62%Shares
10 transactions
Others Institutions Holding AXSM
# of Institutions
403Shares Held
37.3MCall Options Held
507KPut Options Held
540K-
Vanguard Group Inc Valley Forge, PA3.95MShares$460 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$385 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$197 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$177 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$133 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...